ACNT at a glance
ASCENT INDUSTRIES CO. (ACNT, SEC CIK 95953) filed its latest 10-K annual report on March 3, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 4, 2026 and Form 4 insider filings as recently as September 22, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), ASCENT INDUSTRIES CO. (ACNT) reported revenue of $74.9 million (down 57.9% from FY2024) and net income of $867,000. Diluted EPS was $0.09.
- As of September 30, 2026, 17 institutional investment managers tracked by SignalX reported holding ASCENT INDUSTRIES CO. (ACNT) shares worth $24.1 million in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by Mazzaferro Aldo John Jr on June 26, 2026 of 1,500 shares at $14.10 per share.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $74.9M
- −57.9% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 17 funds
- $24.1M · −2 vs prior quarter
- Latest 8-K
- Nov 4, 2026
- Item 2.02
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Risk Factors
- No material changes to risk-factor assessment from the December 31, 2025 Form 10-K
Management Discussion & Analysis
- Q3 revenue $27.1M, up $7.4M or 37.8% YoY, driven by higher shipments and pricing
- Gross margin 26.2% vs 29.7% YoY, while operating income reached $1.6M vs $0.8M loss
- Specialty Chemicals operating income $2.6M vs $2.1M YoY, strongest reported performance
- Cash $28.7M, operating cash used $5.5M, investing cash used $15.9M after Midwest acquisition
- Tariffs, inflation, supply-chain volatility and geopolitical conflicts remain potential headwinds; up to $1.9M capital spending expected in fiscal 2026
AI summary of the ACNT 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Third-quarter financial results announced for period ended September 30, 2026
- Investor-relevant figures and management commentary available in Exhibit 99.1 press release
Item EX-99.1: Item EX-99.1
- Q3 net sales $27.1M, up 37.8% YoY, including 26.3% organic growth excluding Midwest Graphic Sales
- Adjusted EBITDA $3.5M, up $2.1M, with margin expanding to 13.0% from 7.0%
Item 7.01: Regulation FD Disclosure
- Investor presentation scheduled for August 26, 2026, providing updated management messaging to investors
- Exhibit 99.1 includes non-GAAP financial measures and GAAP reconciliations
Item 2.02: Results of Operations and Financial Condition
- Q2 fiscal 2026 financial results released for quarter ended June 30, 2026
- Full operating metrics and management commentary available in Exhibit 99.1 press release
Item EX-99.1: Item EX-99.1
- Q2 net sales rose 37.6% to $25.7M, including $1.9M from Midwest Graphic Sales acquired May 4
- Adjusted EBITDA improved $1.8M to $1.5M, with margin reaching 5.7% versus negative 1.8% year over year
AI summaries of ACNT 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for ACNT
Don't miss the next ACNT filing
- Alerts as it files. A push when ACNT files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut ACNT, by share count.
- Ask anything. An AI agent that reads every ACNT filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Kitchen John Bryan | F | Sep 21, 2026 | 2,269 | $14.70 |
| Mazzaferro Aldo John Jr | Sell | Jun 26, 2026 | 1,500 | $14.10 |
| Mazzaferro Aldo John Jr | A | Jun 10, 2026 | 4,231 | $13.59 |
| Rosenzweig Benjamin L | A | Jun 10, 2026 | 4,415 | $13.59 |
| Giannantonio Carmen Joseph | A | Jun 10, 2026 | 5,519 | $13.59 |
| Hutter Christopher Gerald | A | Jun 10, 2026 | 4,231 | $13.59 |
| Rohen Jeremy | A | Jun 10, 2026 | 4,783 | $13.59 |
| Guy Henry L | A | Jun 10, 2026 | 4,783 | $13.59 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $177.9M | $74.9M |
| Gross Profit | - | $22.1M | $17.2M |
| Operating Income | - | -$5.1M | -$7.0M |
| Net Income | - | -$13.6M | $867K |
| Gross Margin | - | 12.4% | 23.0% |
| Op. Margin | - | -2.9% | -9.4% |
| Net Margin | - | -7.6% | 1.2% |
| Balance Sheet | |||
| Total Assets | $163.3M | $147.3M | $111.9M |
| Equity | $107.4M | $93.5M | $87.0M |
| ROE | - | -14.5% | 1.0% |
| Per Share | |||
| EPS | - | $-1.34 | $0.09 |
| Cash Flow | |||
| Operating CF | - | $14.7M | -$519K |
| CapEx | - | $1.9M | $1.5M |
Source: XBRL data in ASCENT INDUSTRIES CO. (ACNT)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate ACNT share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 17 | $24.1M |
| Q2 2026 | 19 | $27.3M |
| Q1 2026 | 21 | $30.5M |
| Q4 2025 | 18 | $39.3M |
| Q3 2025 | 17 | $30.0M |
| Q2 2025 | 15 | $28.3M |
| Q1 2025 | 14 | $18.1M |
| Q4 2024 | 9 | $14.6M |
- Citadel Advisors LLC+43.8K (+114%)
- Morgan Stanley+6.5K (+6%)
- JPMorgan Chase & Co+3.4K (+509%)
- State Street Corp+1.8K (+5%)
- Two Sigma Investments+1.2K (+1%)
- Millennium Management−41.4K (-44%)
- Renaissance Technologies LLC−37.8K (-14%)
- Goldman Sachs Group−20.9K (-44%)
- Vanguard Capital Management LLC−4.8K (-1%)
- Dimensional Fund Advisors−3.7K (-1%)
- Citigroup+661
- AQR Capital Management−50.8K
- FMR LLC (Fidelity)−1.3K
- Fifth Third Bancorp−101
Source: 13F-HR filings on SEC EDGAR (aggregated from 130 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
ACNT filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 8-K | Nov 4, 2026 | - | Analysis | - |
| 10-Q | Nov 4, 2026 | Sep 30, 2026 | Analysis | |
| 4 | Sep 22, 2026 | - | - | - |
| 8-K | Aug 26, 2026 | - | Analysis | - |
| 8-K | Aug 4, 2026 | - | Analysis | - |
| 10-Q | Aug 4, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Jul 21, 2026 | - | Analysis | - |
| 8-K | Jun 29, 2026 | - | Analysis | - |
| 4 | Jun 29, 2026 | - | - | - |
| 4 | Jun 10, 2026 | - | - | |
| 8-K | Jun 10, 2026 | - | Analysis | |
| 4 | Jun 10, 2026 | - | - | |
| 4 | Jun 10, 2026 | - | - | |
| 4 | Jun 10, 2026 | - | - | |
| 4 | Jun 10, 2026 | - | - | |
| 4 | Jun 10, 2026 | - | - | |
| 8-K | May 18, 2026 | - | Analysis | |
| 8-K | May 6, 2026 | - | Analysis | |
| 10-Q | May 6, 2026 | Mar 31, 2026 | Analysis | |
| 4 | Apr 8, 2026 | - | - | - |
| 4 | Apr 6, 2026 | - | - | - |
| 8-K | Apr 1, 2026 | - | - | - |
| 4 | Mar 30, 2026 | - | - | - |
| 4 | Mar 30, 2026 | - | - | - |
| 4 | Mar 30, 2026 | - | - | - |
Related Health Care companies
- PRM · Perimeter Solutions, Inc.Chemicals & Allied Products
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
- ABT · Abbott LaboratoriesPharmaceutical Preparations
- ABBV · AbbVie IncPharmaceutical Preparations
- ABEO · ABEONA THERAPEUTICS INC.Pharmaceutical Preparations
- ABSI · Absci CorpServices-Commercial Physical & Biological Research
ACNT SEC filings: frequently asked questions
Which institutions hold ACNT stock?
As of September 30, 2026, the largest ASCENT INDUSTRIES CO. (ACNT) holders among the 13F filers tracked by SignalX were Vanguard Capital Management LLC ($4.8 million), Dimensional Fund Advisors ($3.9 million), Renaissance Technologies LLC ($3.4 million), Wells Fargo & Co ($2.9 million), BlackRock ($2.4 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was ACNT's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), ASCENT INDUSTRIES CO. (ACNT) reported revenue of $74.9 million (down 57.9% from FY2024) and net income of $867,000. Diluted EPS was $0.09. The figures come from the XBRL data in the 10-K.
What did ACNT report in its latest 8-K?
ASCENT INDUSTRIES CO. (ACNT) filed an 8-K on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Third-quarter financial results announced for period ended September 30, 2026.
What are the latest ACNT SEC filings?
ASCENT INDUSTRIES CO. (ACNT) filed its latest 10-K annual report on March 3, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 4, 2026 and a Form 4 insider filing on September 22, 2026.
What is ACNT's SEC CIK number?
ASCENT INDUSTRIES CO. (ACNT)'s SEC Central Index Key (CIK) is 95953. EDGAR lists every ACNT filing under that number.
Ask anything about ACNT
The research agent reads ACNT's filings, financials, insider trades and 13F holders, then answers with sources.